🇺🇸 HFA MDI in United States

11 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 23 April 2025 – 23 April 2026
• Total reports: 11

Most-reported reactions

1. Alanine Aminotransferase Increased — 2 reports (18.18%)
2. Abdominal Pain Lower — 1 report (9.09%)
3. Acute Kidney Injury — 1 report (9.09%)
4. Aspartate Aminotransferase Increased — 1 report (9.09%)
5. Asthma — 1 report (9.09%)
6. Blood Creatinine Increased — 1 report (9.09%)
7. Blood Sodium Increased — 1 report (9.09%)
8. Blood Urea Increased — 1 report (9.09%)
9. Confusional State — 1 report (9.09%)
10. Dehydration — 1 report (9.09%)

Source database →

Frequently asked questions

Is HFA MDI approved in United States?

HFA MDI does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for HFA MDI in United States?

AstraZeneca is the originator. The local marketing authorisation holder may differ — check the official source linked above.